Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel
NASDAQ:ILMN

Illumina Q3 2026 Earnings Report

Illumina logo
$273.68 +1.68 (+0.62%)
Closing price 09/30/2026 04:00 PM Eastern
Extended Trading
$275.50 +1.82 (+0.67%)
As of 04:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Illumina EPS Results

Actual EPS
N/A
Consensus EPS
$1.36
Beat/Miss
N/A
One Year Ago EPS
N/A

Illumina Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.15 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Illumina Announcement Details

Quarter
Q3 2026
Date
10/29/2026
Time
After Market Closes
Conference Call Date
Thursday, October 29, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

Illumina Earnings Headlines

Nepean Networks Launches Illuminate IQ, Turning Network Behaviour Into Completed Investigations
September 30 at 9:31 AM  |  financialpost.comF
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?
September 29 at 9:11 PM  |  fool.comhttps://www.fool.com/investing/2026/09/29/where-will-illumina-stock-be-in-5-years-if-its-ai/?source=marketbeat&utm_source=marketbeat&utm_medium=feed&utm_campaign=article&referring_guid=90c94353-2606-4e84-92eb-9801d73dfb80
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
 |  Stansberry Research (Ad)
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
September 29 at 1:43 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/3-reasons-sell-ilmn-1-163202657.html
Is the Options Market Predicting a Spike in Illumina Stock?
September 28 at 5:41 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/options/articles/options-market-predicting-spike-illumina-160300651.html
Bernstein Keeps Their Hold Rating on Illumina (ILMN)
September 27, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/4821804/bernstein-keeps-their-hold-rating-on-illumina-ilmn/
See More Illumina Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Illumina? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Illumina and other key companies, straight to your email.

About Illumina

Illumina (NASDAQ:ILMN) develops and manufactures technologies used to analyze genetic variation and biological function. Its products are primarily based on next-generation sequencing, a method that enables researchers and clinicians to read DNA and RNA for applications including genomic research, disease studies, drug development and clinical testing.

The company offers sequencing instruments, consumables such as reagent kits and flow cells, and related software and informatics solutions. Illumina also provides services and support designed to help customers prepare samples, run sequencing workflows, interpret genomic data and integrate results into research or clinical operations.

Founded in 1998 and headquartered in San Diego, California, Illumina serves customers worldwide, including academic and government research institutions, pharmaceutical and biotechnology companies, hospitals, clinical laboratories and other healthcare organizations. Jacob Thays has served as the company’s chief executive officer since 2024.

View Illumina Profile
Earnings Tools